Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.452
Filter
1.
PLoS Biol ; 22(5): e3002550, 2024 May.
Article in English | MEDLINE | ID: mdl-38768083

ABSTRACT

Alkenyl oxindoles have been characterized as autophagosome-tethering compounds (ATTECs), which can target mutant huntingtin protein (mHTT) for lysosomal degradation. In order to expand the application of alkenyl oxindoles for targeted protein degradation, we designed and synthesized a series of heterobifunctional compounds by conjugating different alkenyl oxindoles with bromodomain-containing protein 4 (BRD4) inhibitor JQ1. Through structure-activity relationship study, we successfully developed JQ1-alkenyl oxindole conjugates that potently degrade BRD4. Unexpectedly, we found that these molecules degrade BRD4 through the ubiquitin-proteasome system, rather than the autophagy-lysosomal pathway. Using pooled CRISPR interference (CRISPRi) screening, we revealed that JQ1-alkenyl oxindole conjugates recruit the E3 ubiquitin ligase complex CRL4DCAF11 for substrate degradation. Furthermore, we validated the most potent heterobifunctional molecule HL435 as a promising drug-like lead compound to exert antitumor activity both in vitro and in a mouse xenograft tumor model. Our research provides new employable proteolysis targeting chimera (PROTAC) moieties for targeted protein degradation, providing new possibilities for drug discovery.


Subject(s)
Cell Cycle Proteins , Oxindoles , Proteolysis , Ubiquitin-Protein Ligases , Humans , Animals , Proteolysis/drug effects , Mice , Ubiquitin-Protein Ligases/metabolism , Oxindoles/pharmacology , Oxindoles/metabolism , Oxindoles/chemistry , Cell Cycle Proteins/metabolism , Transcription Factors/metabolism , Cell Line, Tumor , Xenograft Model Antitumor Assays , Mice, Nude , HEK293 Cells , Structure-Activity Relationship , Proteasome Endopeptidase Complex/metabolism , Azepines/pharmacology , Azepines/chemistry , Azepines/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Female , Bromodomain Containing Proteins , Receptors, Interleukin-17
2.
Phys Chem Chem Phys ; 26(22): 16139-16152, 2024 Jun 06.
Article in English | MEDLINE | ID: mdl-38787638

ABSTRACT

Cyclin-dependent kinase 2 (CDK2) regulates cell cycle checkpoints in the synthesis and mitosis phases and plays a pivotal role in cancerous cell proliferation. The activation of CDK2, influenced by various protein signaling pathways, initiates the phosphorylation process. Due to its crucial role in carcinogenesis, CDK2 is a druggable hotspot target to suppress cancer cell proliferation. In this context, several studies have identified spirooxindoles as an effective class of CDK2 inhibitors. In the present study, three spirooxindoles (SOI1, SOI2, and SOI3) were studied to understand their inhibitory mechanism against CDK2 through a structure-based approach. Molecular docking and molecular dynamics (MD) simulations were performed to explore their interactions with CDK2 at the molecular level. The calculated binding free energy for the spirooxindole-based CDK2 inhibitors aligned well with experimental results regarding CDK2 inhibition. Energy decomposition (ED) analysis identified key binding residues, including I10, G11, T14, R36, F82, K89, L134, P155, T158, Y159, and T160, in the CDK2 active site and T-loop phosphorylation. Molecular mechanics (MM) energy was identified as the primary contributor to stabilizing inhibitor binding in the CDK2 protein structure. Furthermore, the analysis of binding affinity revealed that the inhibitor SOI1 binds more strongly to CDK2 compared to the other inhibitors under investigation. It demonstrated a robust interaction with the crucial residue T160 in the T-loop phosphorylation site, responsible for kinase activation. These insights into the inhibitory mechanism are anticipated to contribute to the development of potential CDK2 inhibitors using the spirooxindole scaffold.


Subject(s)
Cyclin-Dependent Kinase 2 , Indoles , Molecular Docking Simulation , Molecular Dynamics Simulation , Oxindoles , Protein Kinase Inhibitors , Spiro Compounds , Cyclin-Dependent Kinase 2/antagonists & inhibitors , Cyclin-Dependent Kinase 2/metabolism , Cyclin-Dependent Kinase 2/chemistry , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Humans , Oxindoles/chemistry , Oxindoles/pharmacology , Spiro Compounds/chemistry , Spiro Compounds/pharmacology , Indoles/chemistry , Indoles/pharmacology , Thermodynamics , Structure-Activity Relationship , Molecular Structure , Protein Binding , Spirooxindoles
3.
Org Biomol Chem ; 22(17): 3459-3467, 2024 05 01.
Article in English | MEDLINE | ID: mdl-38597668

ABSTRACT

A water mediated three-component reaction of isatin, 4-aminocoumarin, and 1,3-cyclodicarbonyl compounds is reported for the synthesis of spiro[chromeno[4,3-b]cyclopenta[e]pyridine-7,3'-indoline]trione and the spiro[chromeno[4,3-b]quinoline 7,3'-indoline]trione. Up to 27 different spirooxindole derivatives were synthesized by this method. The bioactivity of these spirooxindole derivatives was evaluated and they were found to show antifungal activity against Cercospora arachidicola, Physalospora piricola, Rhizoctonia cerealis, and Fusarium moniliforme.


Subject(s)
Antifungal Agents , Benzopyrans , Indoles , Nitriles , Spiro Compounds , Water , Antifungal Agents/pharmacology , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Spiro Compounds/pharmacology , Spiro Compounds/chemistry , Spiro Compounds/chemical synthesis , Water/chemistry , Indoles/chemistry , Indoles/pharmacology , Indoles/chemical synthesis , Microbial Sensitivity Tests , Oxindoles/pharmacology , Oxindoles/chemical synthesis , Oxindoles/chemistry , Molecular Structure , Structure-Activity Relationship , Fusarium/drug effects
4.
Eur J Med Chem ; 271: 116357, 2024 May 05.
Article in English | MEDLINE | ID: mdl-38636130

ABSTRACT

The oxindole scaffold has been the center of several kinase drug discovery programs, some of which have led to approved medicines. A series of two oxindole matched pairs from the literature were identified where TLK2 was potently inhibited as an off-target kinase. The oxindole has long been considered a promiscuous kinase inhibitor template, but across these four specific literature oxindoles TLK2 activity was consistent, while the kinome profile was radically different ranging from narrow to broad spectrum kinome coverage. We synthesized a large series of analogues, utilizing quantitative structure-activity relationship (QSAR) analysis, water mapping of the kinase ATP binding sites, kinome profiling, and small-molecule x-ray structural analysis to optimize TLK2 inhibition and kinome selectivity. This resulted in the identification of several narrow spectrum, sub-family selective, chemical tool compounds including 128 (UNC-CA2-103) that could enable elucidation of TLK2 biology.


Subject(s)
Drug Discovery , Protein Kinase Inhibitors , Quantitative Structure-Activity Relationship , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/chemical synthesis , Humans , Molecular Structure , Oxindoles/pharmacology , Oxindoles/chemistry , Oxindoles/chemical synthesis , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/metabolism , Dose-Response Relationship, Drug , Models, Molecular
5.
Bioorg Chem ; 147: 107363, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38657527

ABSTRACT

Environment-benign, multicomponent synthetic methodologies are vital in modern pharmaceutical research and facilitates multi-targeted drug development via synergistic approach. Herein, we reported green and efficient synthesis of pyrano[2,3-c]pyrazole fused spirooxindole linked 1,2,3-triazoles using a tea waste supported copper catalyst (TWCu). The synthetic approach involves a one-pot, five-component reaction using N-propargylated isatin, hydrazine hydrate, ethyl acetoacetate, malononitrile/ethyl cyanoacetate and aryl azides as model substrates. Mechanistically, the reaction was found to proceed via in situ pyrazolone formation followed by Knoevenagel condensation, azide alkyne cycloaddition and Michael's addition reactions. The molecules were developed using structure-based drug design. The primary goal is to identifying anti-oxidant molecules with potential ability to modulate α-amylase and DPP4 (dipeptidyl-peptidase 4) activity. The anti-oxidant analysis, as determined via DPPH, suggested that the synthesized compounds, A6 and A10 possessed excellent anti-oxidant potential compared to butylated hydroxytoluene (BHT). In contrast, compounds A3, A5, A8, A9, A13, A15, and A18 were found to possess comparable anti-oxidant potential. Among these, A3 and A13 possessed potential α-amylase inhibitory activity compared to the acarbose, and A3 further emerged as dual inhibitors of both DPP4 and α-amylase with anti-oxidant potential. The relationship of functionalities on their anti-oxidant and enzymatic inhibition was explored in context to their SAR that was further corroborated using in silico techniques and enzyme kinetics.


Subject(s)
Antioxidants , Dipeptidyl Peptidase 4 , Hypoglycemic Agents , Pyrazoles , Triazoles , alpha-Amylases , Pyrazoles/chemistry , Pyrazoles/pharmacology , Pyrazoles/chemical synthesis , Antioxidants/pharmacology , Antioxidants/chemistry , Antioxidants/chemical synthesis , Triazoles/chemistry , Triazoles/pharmacology , Triazoles/chemical synthesis , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/chemical synthesis , Structure-Activity Relationship , alpha-Amylases/antagonists & inhibitors , alpha-Amylases/metabolism , Dipeptidyl Peptidase 4/metabolism , Molecular Structure , Humans , Dose-Response Relationship, Drug , Dipeptidyl-Peptidase IV Inhibitors/chemistry , Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Dipeptidyl-Peptidase IV Inhibitors/chemical synthesis , Molecular Docking Simulation , Picrates/antagonists & inhibitors , Spiro Compounds/chemistry , Spiro Compounds/pharmacology , Spiro Compounds/chemical synthesis , Oxindoles/pharmacology , Oxindoles/chemistry , Oxindoles/chemical synthesis , Benzopyrans , Nitriles
6.
Bioorg Chem ; 146: 107294, 2024 May.
Article in English | MEDLINE | ID: mdl-38507997

ABSTRACT

Oxindoles are potent anti-cancer agents and are also used against microbial and fungal infections and for treating neurodegenerative diseases. These oxindoles are earlier established as estrogen receptor (ER)-targeted agents for killing ER (+) cancer cells. Our previously developed bis-arylidene oxindole, Oxifen (OXF) exhibits effective targeting towards ER (+) cancer cells which has a structural resemblance with tamoxifen. Herein, we have designed and synthesized few structural analogues of OXF such as BPYOX, ACPOX and ACPOXF to examine its cytotoxicity in different cancer as well as non-cancer cell lines and its potential to form self- aggregates in aqueous solution. Among these series of molecules, ACPOXF showed maximum toxicity in colorectal cancer cell line which are ER (-) but it also kills non-cancer cell line HEK-293, thereby reducing its cancer cell selectivity. Incidentally, ACPOXF exhibits self-aggregation, without the help of a co-lipid with nanometric size in aqueous solution. ACPOXF self-aggregate was co-formulated with glucocorticoid receptor (GR) synthetic ligand, dexamethasone (Dex) (called, ACPOXF-Dex aggregate) which could selectively kill ER (-) colorectal cancer cells and also could increase survivability of colon-tumour bearing mice. ACPOXF-Dex induced ROS up-regulation followed by apoptosis through expression of caspase-3. Further, we observed upregulation of antiproliferative factor, p53 and epithelial-to-mesenchymal (EMT) reversal marker E-cadherin in tumour mass. In conclusion, a typical structural modification in ER-targeting Oxifen moiety resulted in its self-aggregation that enabled it to carry a GR-ligand, thus broadening its selective antitumor property especially as colon cancer therapeutics.


Subject(s)
Antineoplastic Agents , Colorectal Neoplasms , Mice , Humans , Animals , Ligands , HEK293 Cells , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Apoptosis , Receptors, Estrogen/metabolism , Oxindoles/chemistry , Colorectal Neoplasms/drug therapy , Cell Line, Tumor , Cell Proliferation
7.
J Am Chem Soc ; 146(11): 7616-7627, 2024 Mar 20.
Article in English | MEDLINE | ID: mdl-38446772

ABSTRACT

Natural products and their analogues are significant sources of therapeutic lead compounds. However, synthetic strategies for generating large collections of these molecules remain a significant challenge. The most difficult step in their synthesis is the design of a common intermediate that can be easily transformed into natural products belonging to different families. This study demonstrates the evolution of synthetic tactics designed to assemble the functionalized piperidines present in indole alkaloids from a common intermediate. More importantly, we also report a previously unknown Ir- and Er-catalyzed dehydrogenative spirocyclization reaction that enables direct access to spirocyclic oxindole alkaloids. As a practical application, the asymmetric total syntheses of 29 natural alkaloids belonging to different families were accomplished by following a uniform synthetic route. The proposed methodology extends the capability of the iridium-catalyzed dehydrogenative coupling reaction to the realm of indole-alkaloid synthesis and provides new opportunities for the efficient preparation of natural product-like molecules.


Subject(s)
Alkaloids , Biological Products , Humans , Stereoisomerism , Indole Alkaloids , Oxindoles
8.
Bioorg Chem ; 146: 107243, 2024 May.
Article in English | MEDLINE | ID: mdl-38457953

ABSTRACT

In the current study, a series of benzimidazole-oxindole conjugates 8a-t were designed and synthesized as type II multi-kinase inhibitors. They exhibited moderate to potent inhibitory activity against BRAFWT up to 99.61 % at 10 µM. Notably, compounds 8e, 8k, 8n and 8s demonstrated the most promising activity, with 99.44 to 99.61 % inhibition. Further evaluation revealed that 8e, 8k, 8n and 8s exhibit moderate to potent inhibitory effects on the kinases BRAFV600E, VEGFR-2, and FGFR-1. Additionally, compounds 8a-t were screened for their cytotoxicity by the NCI, and several compounds showed significant growth inhibition in diverse cancer cell lines. Compound 8e stood out with a GI50 range of 1.23 - 3.38 µM on melanoma cell lines. Encouraged by its efficacy, it was further investigated for its antitumor activity and mechanism of action, using sorafenib as a reference standard. The hybrid compound 8e exhibited potent cellular-level suppression of BRAFWT, VEGFR-2, and FGFR-1 in A375 cell line, surpassing the effects of sorafenib. In vivo studies demonstrate that 8e significantly inhibits the growth of B16F10 tumors in mice, leading to increased survival rates and histopathological tumor regression. Furthermore, 8e reduces angiogenesis markers, mRNA expression levels of VEGFR-2 and FGFR-1, and production of growth factors. It also downregulated Notch1 protein expression and decreased TGF-ß1 production. Molecular docking simulations suggest that 8e binds as a promising type II kinase inhibitor in the target kinases interacting with the key regions in their kinase domain.


Subject(s)
Antineoplastic Agents , Melanoma , Animals , Mice , Sorafenib/pharmacology , Vascular Endothelial Growth Factor Receptor-2 , Molecular Structure , Structure-Activity Relationship , Molecular Docking Simulation , Melanoma/drug therapy , Proto-Oncogene Proteins B-raf , Cell Proliferation , Antineoplastic Agents/pharmacology , Protein Kinase Inhibitors/pharmacology , Benzimidazoles/pharmacology , Oxindoles/pharmacology , Drug Screening Assays, Antitumor
9.
Future Med Chem ; 16(7): 623-645, 2024 04.
Article in English | MEDLINE | ID: mdl-38470247

ABSTRACT

Background: In Alzheimer's disease, butyrylcholinesterase (BuChE) activity gradually increases, while acetylcholinesterase (AChE) activity decreases or remains unchanged. Dual inhibitors have important roles in regulation of synaptic acetylcholine levels and progression of Alzheimer's disease. Methods: 1-(Thiomorpholin-4-ylmethyl)/benzyl-5-trifluoromethoxy-2-indolinones (6-7) were synthesized. AChE and BuChE inhibitory effects were investigated with Ellman's method. Molecular docking studies were performed for analyzing the possible binding interactions at active sites. Results: Compound 6g was the strongest inhibitor against both AChE (Ki = 0.35 µM) and BuChE (Ki = 0.53 µM). It showed higher inhibitory effects than both donepezil and galantamine. Moreover, compound 7m had a higher inhibitory effect than galantamine and the effect was comparable to that of donepezil against both AChE (Ki = 0.69 µM) and BuChE (Ki = 0.95 µM). Conclusion: The benzyl substitution compared with 1-(thiomorpholin-4-ylmethyl) group significantly increased both AChE and BuChE inhibitory effects.


Subject(s)
Alzheimer Disease , Cholinesterase Inhibitors , Humans , Cholinesterase Inhibitors/pharmacology , Donepezil , Galantamine , Molecular Docking Simulation , Butyrylcholinesterase , Acetylcholinesterase , Alzheimer Disease/drug therapy , Oxindoles
10.
Eur J Med Chem ; 268: 116255, 2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38401190

ABSTRACT

Breast cancer (BC) still poses a threat worldwide which demands continuous efforts to present safer and efficacious treatment options via targeted therapy. Beside kinases' aberrations as Aurora B kinase which controls cell division, BC adopts distinct metabolic profiles to meet its high energy demands. Accordingly, targeting both aurora B kinase and/or metabolic vulnerability presents a promising approach to tackle BC. Based on a previously reported indolinone-based Aurora B kinase inhibitor (III), and guided by structural modification and SAR investigation, we initially synthesized 11 sulfonamide-indolinone hybrids (5a-k), which showed differential antiproliferative activities against the NCI-60 cell line panel with BC cells displaying preferential sensitivity. Nonetheless, modest activity against Aurora B kinase (18-49% inhibition) was noted at 100 nM. Screening of a representative derivative (5d) against 17 kinases, which are overexpressed in BC, failed to show significant activity at 1 µM concentration, suggesting that kinase inhibitory activity only played a partial role in targeting BC. Bioinformatic analyses of genome-wide transcriptomics (RNA-sequencing), metabolomics, and CRISPR loss-of-function screens datasets suggested that indolinone-completely responsive BC cell lines (MCF7, MDA-MB-468, and T-47D) were more dependent on mitochondrial oxidative phosphorylation (OXPHOS) compared to partially responsive BC cell lines (MDA-MB-231, BT-549, and HS 578 T). An optimized derivative, TC11, obtained by molecular hybridization of 5d with sunitinib polar tail, manifested superior antiproliferative activity and was used for further investigations. Indeed, TC11 significantly reduced/impaired the mitochondrial respiration, as well as mitochondria-dependent ROS production of MCF7 cells. Furthermore, TC11 induced G0/G1 cell cycle arrest and apoptosis of MCF7 BC cells. Notably, anticancer doses of TC11 did not elicit cytotoxic effects on normal cardiomyoblasts and hepatocytes. Altogether, these findings emphasize the therapeutic potential of targeting the metabolic vulnerability of OXPHOS-dependent BC cells using TC11 and its related sulfonamide-indolinone hybrids. Further investigation is warranted to identify their precise/exact molecular target.


Subject(s)
Antineoplastic Agents , Breast Neoplasms , Humans , Female , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Aurora Kinase B , Oxindoles/pharmacology , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Apoptosis , Sulfonamides/pharmacology , Sulfonamides/therapeutic use , Cell Proliferation
11.
Molecules ; 29(4)2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38398616

ABSTRACT

Phytopathogenic fungi cause plant diseases and economic losses in agriculture. To efficiently control plant pathogen infections, a total of 19 spirotryprostatin A derivatives and 26 spirooxindole derivatives were designed, synthesized, and tested for their antifungal activity against ten plant pathogens. Additionally, the intermediates of spirooxindole derivatives were investigated, including proposing a mechanism for diastereoselectivity and performing amplification experiments. The bioassay results demonstrated that spirotryprostatin A derivatives possess good and broad-spectrum antifungal activities. Compound 4d exhibited excellent antifungal activity in vitro, equal to or higher than the positive control ketoconazole, against Helminthosporium maydis, Trichothecium roseum, Botrytis cinerea, Colletotrichum gloeosporioides, Fusarium graminearum, Alternaria brassicae, Alternaria alternate, and Fusarium solan (MICs: 8-32 µg/mL). Compound 4k also displayed remarkable antifungal activity against eight other phytopathogenic fungi, including Fusarium oxysporium f. sp. niveum and Mycosphaerella melonis (MICs: 8-32 µg/mL). The preliminary structure-activity relationships (SARs) were further discussed. Moreover, molecular docking studies revealed that spirotryprostatin A derivatives anchored in the binding site of succinate dehydrogenase (SDH). Therefore, these compounds showed potential as natural compound-based chiral fungicides and hold promise as candidates for further enhancements in terms of structure and properties.


Subject(s)
Antifungal Agents , Benzopyrans , Fungicides, Industrial , Nitriles , Oxindoles , Piperazines , Spiro Compounds , Antifungal Agents/chemistry , Molecular Docking Simulation , Structure-Activity Relationship , Fungicides, Industrial/pharmacology
12.
Analyst ; 149(4): 1229-1237, 2024 Feb 12.
Article in English | MEDLINE | ID: mdl-38224234

ABSTRACT

Fibrillation of proteins and polypeptides, which leads to the deposition of plaques in cells and tissues has been widely associated with many neuropathological diseases. Inhibition of protein misfolding and aggregation is crucial for the prevention and treatment of these conditions. The growing interest in identifying inhibitor molecules to prevent the formation of fibrils in vivo has led to the results highlighted in this study. Due to their hydrophobic structure and potential to readily cross the blood brain barrier, a library of spirooxindole compounds were synthesized with those labelled Hd-63, Hd-66 and Hd-74 proving to be the most potent against fibril formation. Our spectroscopic analysis provides detailed insight, that the introduction of these spirooxindole compounds leads to morphological changes in the mechanism of fibril formation which prevent the formation of highly ordered fibrils, instead results in the formation of disordered aggregates which are not fibrillar in nature.


Subject(s)
Amyloid , Benzopyrans , Neurodegenerative Diseases , Nitriles , Oxindoles , Spiro Compounds , Humans , Neurodegenerative Diseases/drug therapy , Spirooxindoles , Peptides/chemistry
13.
Anal Methods ; 16(7): 1083-1092, 2024 02 15.
Article in English | MEDLINE | ID: mdl-38284158

ABSTRACT

Atherosclerosis (AS) is a chronic inflammatory disease with disorders of lipid metabolism. Metabolic disorders, inflammation and lipid deposition are prominent pathological features of atherosclerosis. Isorhynchophylline (IRN) has pharmacological effects such as protection of vascular endothelial cells, anti-inflammatory, anti-thrombotic, and anti-smooth muscle cell proliferation. However, it is unclear whether IRN is efficacious in atherosclerosis. In the present study, we verified the pharmacological efficacy and hepatoprotective effects of IRN in intervening in AS. LC-MS-based serum untargeted metabolomics was performed to search for potential biomarkers and related pathways in IRN-treated AS in ApoE-/- mice. Fifty-eight biomarkers were metabolically disturbed in the model mice compared to controls. Thirteen biomarkers showed optimal recovery methods after IRN-40 mg ml-1 intervention. We identified three metabolic pathways involved in IRN: glycerophospholipid metabolism, linoleic acid metabolism, and alpha-linolenic acid metabolism. These findings provide a research basis for the intervention of IRN in atherosclerosis.


Subject(s)
Atherosclerosis , Endothelial Cells , Oxindoles , Mice , Animals , Atherosclerosis/drug therapy , Apolipoproteins E , Biomarkers
14.
Bioorg Chem ; 143: 107091, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38183683

ABSTRACT

This scientific review documents the recent progress of C3-spirooxindoles chemistry (synthesis and reaction mechanism) and their bioactivities, focusing on the promising results as well as highlighting the biological mechanism via the reported molecular docking findings of the most bioactive derivatives. C3-Spirooxindoles are attractive bioactive agents and have been found in a variety of natural compounds, including alkaloids. They are widely investigated in the field of medicinal chemistry and play a key role in medication development, such as antivirals, anticancer agents, antimicrobials, etc. Regarding organic synthesis, several traditional and advanced strategies have been reported, particularly those that started with isatin derivatives.


Subject(s)
Benzopyrans , Nitriles , Spiro Compounds , Spirooxindoles , Molecular Docking Simulation , Spiro Compounds/pharmacology , Spiro Compounds/chemistry , Oxindoles/pharmacology , Oxindoles/chemistry
15.
Med Chem ; 20(1): 63-77, 2024.
Article in English | MEDLINE | ID: mdl-37723960

ABSTRACT

BACKGROUND: Since CDKs have been demonstrated to be overexpressed in a wide spectrum of human malignancies, their inhibition has been cited as an effective technique for anticancer drug development. METHODS: In this context, new bis-oxindole/spiro-triazole-oxindole anti-breast cancer drugs with potential CDK4 inhibitory effects were produced in this work. The novel series of bis-oxindole/spirotriazole- oxindole were synthesized from the reaction of bis-oxindole with the aniline derivatives then followed by 1,3-dipolar cycloaddition of hydrazonoyl chloride. RESULTS: The structure of these bis-oxindole/spiro-triazole-oxindole series was proven based on their spectral analyses. Most bis-oxindole and bis-spiro-triazole-oxindole compounds effectively inhibited the growth of MCF-7 (IC50 = 2.81-17.61 µM) and MDA-MB-231 (IC50 = 3.23-7.98 µM) breast cancer cell lines with low inhibitory activity against normal WI-38 cells. While the reference doxorubicin showed IC50 values of 7.43 µM against MCF-7 and 5.71 µM against the MDA-MB-231 cell line. Additionally, compounds 3b, 3c, 6b, and 6d revealed significant anti-CDK4 activity (IC50 = 0.157- 0.618 µM) compared to palbociclib (IC50 = 0.071 µM). Subsequent mechanistic investigations demonstrated that 3c was able to trigger tumor cell death through the induction of apoptosis. Moreover, it stimulated cancer cell cycle arrest in the G1 phase. Furthermore, western blotting disclosed that the 3c-induced cell cycle arrest may be mediated through p21 upregulation. CONCLUSION: According to all of the findings, bis-oxindole 3c shows promise as a cancer treatment targeting CDK4.


Subject(s)
Antineoplastic Agents , Breast Neoplasms , Humans , Female , Structure-Activity Relationship , Triazoles , MCF-7 Cells , Breast Neoplasms/pathology , Apoptosis , Oxindoles/pharmacology , Oxindoles/chemistry , Antineoplastic Agents/chemistry , Cell Proliferation , Cell Line, Tumor , Drug Screening Assays, Antitumor , Molecular Structure , Cyclin-Dependent Kinase 4/metabolism , Cyclin-Dependent Kinase 4/pharmacology
16.
Chemistry ; 30(8): e202303519, 2024 Feb 07.
Article in English | MEDLINE | ID: mdl-38018776

ABSTRACT

Three unusual ajmaline-macroline type bisindole alkaloids, alsmaphylines A-C, together with their postulated biogenetic precursors, were isolated from the stem barks and leaves of Alstonia macrophylla via the building blocks-based molecular network (BBMN) strategy. Alsmaphyline A represents a rare ajmaline-macroline type bisindole alkaloid with an S-shape polycyclic ring system. Alsmaphylines B and C are two novel ajmaline-macroline type bisindole alkaloids with N-1-C-21' linkages, and the former possesses an unconventional stacked conformation due to the presence of intramolecular noncovalent interactions. The chemical structures including absolute configurations of alsmaphylines A-C were established by comprehensive spectroscopic analyses, electronic circular dichroism (ECD) calculations, and single-crystal X-ray crystallography. In addition, a plausible biosynthetic pathway of these bisindole alkaloids as well as their ability to promote the protein synthesis on HT22 cells were discussed.


Subject(s)
Alkaloids , Alstonia , Oxindoles , Alstonia/chemistry , Ajmaline , Indole Alkaloids/chemistry , Molecular Structure , Alkaloids/chemistry
17.
Chemistry ; 30(5): e202303027, 2024 Jan 22.
Article in English | MEDLINE | ID: mdl-37755456

ABSTRACT

Design strategies that can access natural-product-like chemical space in an efficient manner may facilitate the discovery of biologically relevant compounds. We have employed a divergent intermediate strategy to construct an indole alkaloid-inspired compound collection derived from two different molecular design principles, i.e. biology-oriented synthesis and pseudo-natural products. The divergent intermediate was subjected to acid-catalyzed or newly discovered Sn-mediated conditions to selectively promote intramolecular C- or N-acylation, respectively. After further derivatization, a collection totalling 84 compounds representing four classes was obtained. Morphological profiling via the cell painting assay coupled with a subprofile analysis showed that compounds derived from different design principles have different bioactivity profiles. The subprofile analysis suggested that a pseudo-natural product class is enriched in modulators of tubulin, and subsequent assays led to the identification of compounds that suppress in vitro tubulin polymerization and mitotic progression.


Subject(s)
Alkaloids , Antineoplastic Agents , Biological Products , Oxindoles , Tubulin , Indole Alkaloids/chemistry , Biological Products/chemistry
18.
Phytochemistry ; 218: 113936, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38104748

ABSTRACT

Eight previously undescribed compounds comprising pyrrole-2-carboxaldehyde derivatives, namely periplanpyrroles A-D (1-4), spirooxindole derivatives perispirooxindoles A (5) and B (6), and the phenolic compounds periplanetols G (7) and H (8), along with eight known compounds were isolated from the 70% ethanol extract of the whole bodies of Periplaneta americana. Their structures including absolute configurations were unambiguously identified by comprehensive spectroscopic analyses and computational methods. In addition, all compounds were evaluated for their activities against triple negative breast cancer in vitro. The wound healing assay revealed that 7, 9, and 11 significantly inhibit the migration of BT549 and MDA-MB-231 cells. Further observations made in Western blotting experiments showed that 7 could dose-dependently decrease the protein level of vimentin and N-cadherin in MDA-MB-231 and BT549 cells.


Subject(s)
Benzopyrans , Nitriles , Oxindoles , Periplaneta , Spiro Compounds , Triple Negative Breast Neoplasms , Humans , Animals , Periplaneta/chemistry , Triple Negative Breast Neoplasms/drug therapy , Ethanol , Wound Healing
19.
J Am Chem Soc ; 146(1): 118-124, 2024 Jan 10.
Article in English | MEDLINE | ID: mdl-38153983

ABSTRACT

Corynantheine-type alkaloids are major components of the Mitragyna speciosa, also known as kratom, that exhibit unique pharmacological activity. However, no universal method to prepare these alkaloids has been reported. Disclosed herein is a catalytic, asymmetric platform that enables rapid access to corynantheine alkaloids. The first enantioselective total synthesis of (-)-corynantheidine pseudoindoxyl is described. The first asymmetric syntheses of (+)-corynoxine and (-)-corynoxine B were also achieved, along with enantioselective syntheses of (-)-corynantheidol and (-)-corynantheidine. Through this work, all series of corynantheine alkaloids including indole, spirooxindole, and pseudoindoxyl can now be accessed in the laboratory, enabling comprehensive biological investigation of kratom alkaloids to be undertaken.


Subject(s)
Benzopyrans , Nitriles , Pausinystalia , Secologanin Tryptamine Alkaloids , Spiro Compounds , Oxindoles , Secologanin Tryptamine Alkaloids/pharmacology
20.
Environ Sci Pollut Res Int ; 30(56): 119151-119167, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37919493

ABSTRACT

We report on the preparation of copper iodide nanoparticles (NPs) immobilized on vitamin B3-modified graphene (CuI/GO-VB) nanocomposite and its application for the synthesis of oxazolidinone compounds using a remarkable carboxylative cyclization method via the reaction of arylacetylene, aldehyde and benzylamine derivatives under an atmospheric pressure of CO2 gas. The CuI/GO-VB catalyst was prepared from graphene oxide (GO), vitamin B3 (VB) and CuI using a two-step procedure; firstly graphene-based composite (GO-VB) was synthesized by the reaction of GO and nicotinoyl chloride, followed by the immobilization of CuI NPs on GO-VB. The CuI/GO-VB nanocomposite was fully identified with X-ray diffraction (XRD), Fourier-transform infrared (FT-IR) spectroscopy, field emission scanning electron microscopy (FESEM), energy dispersive spectroscopy (EDS), inductively coupled plasma optical emission spectroscopy (ICP-OES), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), and X-ray photoelectron spectroscopy (XPS). The catalytic performance of the CuI/GO-VB heterogeneous catalyst was investigated in carboxylative cyclization for the synthesis of oxazolidinone compounds under an atmospheric pressure of CO2 gas at 100οC in solvent-, base-, and additive-free conditions; the corresponding oxazolidinone compounds were obtained in 79-94% yield. The hot filtration results indicated that CuI/GO-VB nanocomposite was a heterogeneous catalyst and showed a good reusability for 5 runs without a significant decrease in its catalytic performance.


Subject(s)
Graphite , Nanocomposites , Nanoparticles , Oxazolidinones , Copper/chemistry , Graphite/chemistry , Oxindoles , Carbon Dioxide , Iodides , Spectroscopy, Fourier Transform Infrared , Nanoparticles/chemistry , Nanocomposites/chemistry , Catalysis , Vitamins
SELECTION OF CITATIONS
SEARCH DETAIL
...